MALVERN, Pennsylvania, March 13, 2017 /PRNewswire/ --
Center Point Clinical Services, creator of the world's first Siteless CRO platform, announced today the publication by The Journal of Clinical Therapeutics of an article authored by the company's CEO Mr. Joe Martinez. Article contributors include Cedarville University School of Pharmacy's Emily Laswell, Assistant Professor of Pharmacy Practice, PharmaD, BCPS, Jeb Ballentine, Associate Professor of Pharmacy Practice, PharmD and Stephanie Cailor, BSPS. The article titled Frequency and Impact of Pharmacist Interventions in Clinical Trial Patients With Diabetes will be published in the April 2017 (Volume 38, issue 3) edition of the printed journal. It can now also be accessed online here .
(Logo: http://photos.prnewswire.com/prnh/20160317/345390LOGO )
The article examines the impact of pharmacist interventions on medication adherence and adverse events in clinical trials focusing on diabetes. Clinical trial research pharmacists (CTRPs), provided by Center Point Clinical Services, were engaged to communicate with patients to support clinical trial protocol adherence, retention and outcomes in 12 clinical trials involving two non-insulin glucose lowering medications (NIGLMs). Pharmacists called enrolled study participants at specific time points during the trials and were available 24/7 to receive patient calls for most trials. During each telephone call, the number and types of interventions were documented and descriptive statistics were performed.
Mr. Martinez, said, "Just over 25 thousand calls were made during these 12 studies. Of these calls, 45.5% had at least one intervention involving 92.3% of the patients. Interestingly, 56% of the interventions were classified as high impact and that would have seriously negatively influenced the trial outcomes."
Mr. Martinez continued, "We learned from this initiative that pharmacists are indeed able to help improve the clinical trial process. We found that the pharmacists successfully supported and addressed multiple types of interventions related to medication management, use, and adverse events. The result was better patient compliance, outcomes and ultimately, more reliable and robust study results."
About Center Point Clinical Services
Center Point Clinical Services LLC. is a specialty, site-less, technology contract research organization (CRO) that helps pharmaceutical, biotech, and medical device companies successfully reach their regulatory and commercialization goals in less time and at a lower cost than competitors. The company's evolutionary Site-less CRO model helps to recruit patients faster, identify and address patient issues in real-time and complete trials within time and cost projections. The company offers two premier signature services. The first is the Clinical Trial Research Pharmacist (CTRP®) program, which uses only licensed, specially trained pharmacists to communicate with patients. Center Point is the only CRO to offer such a unique and effective service. CTRP has repeatedly demonstrated improved patient retention, medication compliance and overall outcomes in clinical trials. The second service includes a series of practical signature study solutions intended to support regulatory and commercialization goals. These include: real world evidence (RWE) analysis and publications, health economic outcomes and research (HEOR), market access and reimbursement support, industry standard quality metrics data, and scientific publications. For more information please visit www.centerpointclinicalservices.com
Like us on Facebook.
Follow us on Twitter and LinkedIn
Press Contact: Marjie Hadad MH Communications +1-844-287-2877 Ext 9 [email protected]
SOURCE Center Point Clinical Services
Advertisement
Center Point Clinical Services, creator of the world's first Siteless CRO platform, announced today the publication by The Journal of Clinical Therapeutics of an article authored by the company's CEO Mr. Joe Martinez. Article contributors include Cedarville University School of Pharmacy's Emily Laswell, Assistant Professor of Pharmacy Practice, PharmaD, BCPS, Jeb Ballentine, Associate Professor of Pharmacy Practice, PharmD and Stephanie Cailor, BSPS. The article titled Frequency and Impact of Pharmacist Interventions in Clinical Trial Patients With Diabetes will be published in the April 2017 (Volume 38, issue 3) edition of the printed journal. It can now also be accessed online here .
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20160317/345390LOGO )
The article examines the impact of pharmacist interventions on medication adherence and adverse events in clinical trials focusing on diabetes. Clinical trial research pharmacists (CTRPs), provided by Center Point Clinical Services, were engaged to communicate with patients to support clinical trial protocol adherence, retention and outcomes in 12 clinical trials involving two non-insulin glucose lowering medications (NIGLMs). Pharmacists called enrolled study participants at specific time points during the trials and were available 24/7 to receive patient calls for most trials. During each telephone call, the number and types of interventions were documented and descriptive statistics were performed.
Mr. Martinez, said, "Just over 25 thousand calls were made during these 12 studies. Of these calls, 45.5% had at least one intervention involving 92.3% of the patients. Interestingly, 56% of the interventions were classified as high impact and that would have seriously negatively influenced the trial outcomes."
Mr. Martinez continued, "We learned from this initiative that pharmacists are indeed able to help improve the clinical trial process. We found that the pharmacists successfully supported and addressed multiple types of interventions related to medication management, use, and adverse events. The result was better patient compliance, outcomes and ultimately, more reliable and robust study results."
About Center Point Clinical Services
Center Point Clinical Services LLC. is a specialty, site-less, technology contract research organization (CRO) that helps pharmaceutical, biotech, and medical device companies successfully reach their regulatory and commercialization goals in less time and at a lower cost than competitors. The company's evolutionary Site-less CRO model helps to recruit patients faster, identify and address patient issues in real-time and complete trials within time and cost projections. The company offers two premier signature services. The first is the Clinical Trial Research Pharmacist (CTRP®) program, which uses only licensed, specially trained pharmacists to communicate with patients. Center Point is the only CRO to offer such a unique and effective service. CTRP has repeatedly demonstrated improved patient retention, medication compliance and overall outcomes in clinical trials. The second service includes a series of practical signature study solutions intended to support regulatory and commercialization goals. These include: real world evidence (RWE) analysis and publications, health economic outcomes and research (HEOR), market access and reimbursement support, industry standard quality metrics data, and scientific publications. For more information please visit www.centerpointclinicalservices.com
Like us on Facebook.
Follow us on Twitter and LinkedIn
Press Contact: Marjie Hadad MH Communications +1-844-287-2877 Ext 9 [email protected]
SOURCE Center Point Clinical Services
